| Interferences with thyroid function immunoassays: clinical implications and detection algorithm J Favresse, MC Burlacu, D Maiter, D Gruson Endocrine reviews 39 (5), 830-850, 2018 | 205 | 2018 |
| D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications J Favresse, G Lippi, PM Roy, B Chatelain, H Jacqmin, H Ten Cate, ... Critical reviews in clinical laboratory sciences 55 (8), 548-577, 2018 | 187 | 2018 |
| Antibody titres decline 3-month post-vaccination with BNT162b2 J Favresse, JL Bayart, F Mullier, M Elsen, C Eucher, S Van Eeckhoudt, ... Emerging microbes & infections 10 (1), 1495-1498, 2021 | 156 | 2021 |
| Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers JL Bayart, J Douxfils, C Gillot, C David, F Mullier, M Elsen, C Eucher, ... Vaccines 9 (10), 1092, 2021 | 116 | 2021 |
| Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies J Favresse, C Eucher, M Elsen, M Tré-Hardy, JM Dogné, J Douxfils Clinical chemistry 66 (8), 1104-1106, 2020 | 109 | 2020 |
| Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies M Tré‐Hardy, A Wilmet, I Beukinga, J Favresse, JM Dogné, J Douxfils, ... Journal of medical virology 93 (2), 803-811, 2021 | 99 | 2021 |
| Head-to-head comparison of rapid and automated antigen detection tests for the diagnosis of SARS-CoV-2 infection J Favresse, C Gillot, M Oliveira, J Cadrobbi, M Elsen, C Eucher, ... Journal of clinical medicine 10 (2), 265, 2021 | 90 | 2021 |
| Neutralizing antibodies in COVID-19 patients and vaccine recipients after two doses of BNT162b2 J Favresse, C Gillot, L Di Chiaro, C Eucher, M Elsen, S Van Eeckhoudt, ... Viruses 13 (7), 1364, 2021 | 85 | 2021 |
| Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination J Douxfils, J Favresse, JM Dogné, T Lecompte, S Susen, C Cordonnier, ... Thrombosis research 203, 163-171, 2021 | 76 | 2021 |
| Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2) J Favresse, JL Bayart, F Mullier, JM Dogné, M Closset, J Douxfils Clinical Microbiology and Infection 27 (9), 1351. e5-1351. e7, 2021 | 74 | 2021 |
| Evaluation of the DOAC-Stop® procedure to overcome the effect of DOACs on several thrombophilia screening tests J Favresse, B Lardinois, L Sabor, B Devalet, J Vandepapeliere, ... TH Open 2 (02), e202-e209, 2018 | 70 | 2018 |
| Persistence of anti-SARS-CoV-2 antibodies depends on the analytical kit: a report for up to 10 months after infection J Favresse, C Eucher, M Elsen, C Gillot, S Van Eeckhoudt, JM Dogné, ... Microorganisms 9 (3), 556, 2021 | 59 | 2021 |
| Pseudothrombocytopenia—a review on causes, occurrence and clinical implications B Lardinois, J Favresse, B Chatelain, G Lippi, F Mullier Journal of clinical medicine 10 (4), 594, 2021 | 54 | 2021 |
| Analytical sensitivity of six SARS-CoV-2 rapid antigen tests for omicron versus delta variant JL Bayart, J Degosserie, J Favresse, C Gillot, M Didembourg, HP Djokoto, ... Viruses 14 (4), 654, 2022 | 53 | 2022 |
| NETosis and the immune system in COVID-19: mechanisms and potential treatments C Gillot, J Favresse, F Mullier, T Lecompte, JM Dogne, J Douxfils Frontiers in pharmacology 12, 708302, 2021 | 52 | 2021 |
| Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS13 activity C Valsecchi, M Mirabet, I Mancini, M Biganzoli, L Schiavone, S Faraudo, ... Thrombosis and haemostasis 119 (11), 1767-1772, 2019 | 49 | 2019 |
| Interferences in immunoassays: review and practical algorithm L Wauthier, M Plebani, J Favresse Clinical Chemistry and Laboratory Medicine (CCLM) 60 (6), 808-820, 2022 | 45 | 2022 |
| Confounding factors influencing the kinetics and magnitude of serological response following administration of BNT162b2 JL Bayart, L Morimont, M Closset, G Wieërs, T Roy, V Gerin, M Elsen, ... Microorganisms 9 (6), 1340, 2021 | 41 | 2021 |
| An original ELISA-based multiplex method for the simultaneous detection of 5 SARS-CoV-2 IgG antibodies directed against different antigens C Gillot, J Douxfils, J Cadrobbi, K Laffineur, JM Dogné, M Elsen, C Eucher, ... Journal of clinical medicine 9 (11), 3752, 2020 | 38 | 2020 |
| High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies A Mairesse, J Favresse, C Eucher, M Elsen, M Tré-Hardy, C Haventith, ... Clinical biochemistry 86, 23-27, 2020 | 29 | 2020 |
Jean-Louis BayartPharmD, Specialist in Laboratory MedicineVerified email at cspo.be
Jean-Louis BayartPharmD, Specialist in Laboratory MedicineVerified email at cspo.be